Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30

Core Points - Co-Diagnostics, Inc. will participate in the Lytham Partners Fall 2025 Investor Conference, hosting a webcast presentation and one-on-one meetings with institutional investors on September 30, 2025 [1][2]. Company Overview - Co-Diagnostics, Inc. is a molecular diagnostics company based in Utah, specializing in the development, manufacturing, and marketing of advanced diagnostic technologies [3]. - The company's proprietary technology is utilized for tests designed to detect and analyze nucleic acid molecules (DNA or RNA) [3]. - Co-Diagnostics is also developing specific tests for its Co-Dx PCR at-home and point-of-care platform, which is subject to regulatory review and not currently for sale [3]. Event Details - The company's presentation is scheduled for 4:15 p.m. ET on the day of the conference, and it will be accessible via the conference homepage or directly through a provided link [2]. - A replay of the webcast will be available after the event, and the presentation slide deck can be found on the company's investor relations website [2]. - Management will engage in virtual one-on-one meetings throughout the event, with arrangements facilitated through Lytham Partners [3].